» Authors » Christopher Levi

Christopher Levi

Explore the profile of Christopher Levi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 160
Citations 4124
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Kaufmann J, Harshfield E, Gensicke H, Wegener S, Michel P, Kagi G, et al.
JAMA Neurol . 2024 May; 81(6):630-637. PMID: 38739383
Importance: Cervical artery dissection is the most common cause of stroke in younger adults. To date, there is no conclusive evidence on which antithrombotic therapy should be used to treat...
12.
Thomas L, Holliday E, Attia J, Levi C
J Man Manip Ther . 2023 Aug; 32(2):173-181. PMID: 37651397
Objectives: Cervical arterial dissection (CAD) is an important cause of stroke in young people which may be missed because early features may mimic migraine or a musculoskeletal presentation. The study...
13.
Sharobeam A, Lin L, Lam C, Garcia-Esperon C, Gawarikar Y, Patel R, et al.
Stroke Vasc Neurol . 2023 May; 9(1):30-37. PMID: 37247875
Background: The optimal time to commence anticoagulation in patients with atrial fibrillation (AF) after ischaemic stroke or transient ischaemic attack (TIA) is unclear, with guidelines differing in recommendations. A limitation...
14.
Middleton S, Dale S, McElduff B, Coughlan K, Mcinnes E, Mikulik R, et al.
Eur Stroke J . 2023 Apr; 8(1):132-147. PMID: 37021183
Introduction: Poor adoption of stroke guidelines is a problem internationally. The Quality in Acute Stroke Care (QASC) trial demonstrated significant reduction in death and disability with facilitated implementation of nurse-initiated....
15.
Werdiger F, Parsons M, Visser M, Levi C, Spratt N, Kleinig T, et al.
Front Neurol . 2023 Mar; 14:1098562. PMID: 36908587
Introduction: Computed tomography perfusion (CTP) imaging is widely used in cases of suspected acute ischemic stroke to positively identify ischemia and assess suitability for treatment through identification of reversible and...
16.
Chen C, Ouyang M, Ong S, Zhang L, Zhang G, Delcourt C, et al.
EClinicalMedicine . 2023 Feb; 57:101849. PMID: 36820100
Background: Intensive blood pressure lowering may adversely affect evolving cerebral ischaemia. We aimed to determine whether intensive blood pressure lowering altered the size of cerebral infarction in the 2196 patients...
17.
Karimi-Haghighi S, Pandamooz S, Jurek B, Fattahi S, Safari A, Azarpira N, et al.
Mol Neurobiol . 2023 Jan; 60(5):2587-2601. PMID: 36694047
The short-term therapeutic impacts of stem cells and their derivatives were frequently reported in preclinical investigations of ischemic stroke (IS); however, several drawbacks including accessibility, abundancy, and ethical concerns limited...
18.
Bivard A, Garcia-Esperon C, Churilov L, Spratt N, Russell M, Campbell B, et al.
Int J Stroke . 2023 Jan; 18(6):751-756. PMID: 36655938
Rationale: Alteplase is the only approved thrombolytic agent for acute stroke. An alternative plasminogen activator, tenecteplase, has been previously shown to increase early biological effectiveness (reperfusion) resulting in early clinical...
19.
Gao L, Moodie M, Levi C, Lin L, Cheng X, Kleinig T, et al.
Cerebrovasc Dis . 2022 Dec; 52(2):137-144. PMID: 36516799
Introduction: We aimed to assess the long-term health outcomes and costs of endovascular thrombectomy (EVT) using clinical trials and real-world evidence in patients with large ischaemic core. Methods: Both clinical...
20.
Dempsey K, Ferguson C, Walczak A, Middleton S, Levi C, Morton R
Syst Rev . 2022 Nov; 11(1):237. PMID: 36352475
Background: Empirical evidence suggests data and insights from the clinical practice guidelines and clinical quality registries are not being fully utilised, leaving health service managers, clinicians and providers without clear...